Bristol-Myers Squibb Company Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 192 Posts
1 2 3 ... 12
4 Big Drugmakers To Bet On After A Great Earnings Season
Article By: Zacks Investment Research Friday, November 15, 2019 8:35 AM EST
New drugs and label expansions of blockbuster drugs drove the top line of most of the big shots backed by higher demand, which countered headwinds from generic/biosimilar competition for older medicines.
In this article: BMY, GSK, MRK, NVO Also: JNJ, PFE, ABBV
Read
Bristol-Myers Squibb Posts Q3 Earnings Beat, Raises Full-Year Guidance
Article By: Benzinga Thursday, October 31, 2019 10:07 AM EST
Bristol-Myers Squibb reported third-quarter earnings of $1.17 per share Thursday, beating the analyst consensus estimate of $1.07.
In this article: BMY
Read
E No Memorial Today
Article By: Vivian Lewis Tuesday, October 22, 2019 11:55 PM EST
Our sold stocks are crashing and our bought stocks climbing! We have reports from the USA, Japan, Israel, Denmark, and Canada, and that's only about pharmaceuticals. We also have exciting news about lung cancer, but some bad news from India...
In this article: BMY, NVO, ESALY, GNCGY, NPSNY, BIIB, INFY, TEVA, ZYME, PROSY, EC, SLB, SQM, CMDXF, JMPLY, ITRN, LBTYA, LBTYK, CZZ, TMRAF, SAN, ANFGF, AZSEY, ACAT, CBBYF
Read
Back To The Negotiating Table
Article By: Mati Greenspan Tuesday, August 27, 2019 8:11 AM EST
The market focus going into last week was shifting from the US-China trade war to the Fed and the monetary policy of other central banks.
In this article: BITCOMP, DISH, BYND, BMY, WORK, LYFT
Read
Bristol-Myers Passes $74 Bln Deal’s First Big Exam
Article By: Lipper Alpha Insight Tuesday, August 27, 2019 4:24 AM EST
Bristol-Myers Squibb boss Giovanni Caforio can heave a sigh of relief. The drugmaker, valued at $76 billion at Friday’s close, is stretching to buy Celgene for almost as much again.
In this article: CELG, BMY
Read
Four High Earnings Yield Stocks To Bolster Your Portfolio
Article By: Zacks Investment Research Tuesday, August 20, 2019 10:59 AM EST
If you are not sure whether to invest your money in bonds or stocks, a key parameter that can show you the right direction is earnings yield.
In this article: BMY, CMC, DAL, UAL
Read
Bristol-Myers Squibb Is Undervalued
Article By: Andres Cardenal Monday, August 19, 2019 4:36 PM EST
Bristol-Myers Squibb is under considerable pressure, the stock has declined by more than 25% from its highs of the year due to generalized negativity towards the drug manufacturing sector and the uncertainty produced by the Celgene acquisition.
In this article: BMY Also: CELG
Read
Week In Review: How Trump's Policies Moved Stocks - July 28th, 2019
Article By: The Fly Sunday, July 28, 2019 7:47 PM EST
DOJ probes big tech as Trump says no to Apple request for tariff relief.
In this article: AZN, BMY, GSK, JNJ, LLY, MRK, NVS, PFE, SNY, WDC, RHHBY, AAPL, AMZN, AVGO, CSCO, GOOG, INTC, MU, QCOM, FB, GOOGL
Read
Bristol-Myers Squibb Q2 Earnings And Revenues Beat Estimates
Article By: Zacks Investment Research Thursday, July 25, 2019 10:13 AM EST
Bristol-Myers Squibb came out with quarterly earnings of $1.18 per share.
In this article: BMY
Read
Week In Review: How Trump's Policies Moved Stocks - July 21, 2019
Article By: The Fly Sunday, July 21, 2019 6:44 PM EST
Trump is looking into Pentagon's JEDI contract as US-China trade talks stall. The contract, set to be awarded to Amazon or Microsoft, is worth up to $10B. Plus Trump continues his pressure on the FED and some pharmaceutical news,
In this article: AZN, BMY, GSK, JNJ, LLY, MRK, NVS, PFE, SNY, RHHBY, AMZN, MSFT, ORCL
Read
The Week Ahead In Biotech: Pharma Earnings Pick Up Pace
Article By: Benzinga Saturday, July 20, 2019 8:56 PM EST
Biotech stocks had a relatively muted performance last week. Johnson & Johnson kickstarted the second-quarter reporting season for big pharma companies, beating forecasts and an upward adjustment to its full-year sales guidance.
In this article: BMY, DGX, EW, JNJ, MRK, ANIK, BIIB, CELG, BHVN
Read
Week In Review: How Trump's Policies Moved Stocks - July 14, 2019
Article By: The Fly Sunday, July 14, 2019 4:28 PM EST
Trump abandons drug rebate proposal, criticizes Facebook's Libra digital currency, and more...
In this article: BITCOMP, ABC, AZN, BA, BMY, CAH, CI, CVS, CVX, GE, GSK, JNJ, LLY, LMT, MCK, MRK, NVS, PFE, RTN, SNY, UNH, RHHBY, LHCG, AMED, PDCO, PSX, FB, ANTM, LIBRA
Read
Celgene Corp And Bristol Myers - Different Characteristics Companies
Video By: Chuck Carnevale Thursday, July 11, 2019 9:16 PM EST
Bristol Myers is a semi-cyclical dividend growth stock whereas Celgene is much more of a growth stock with extremely higher growth.
In this video: BMY, CELG
Watch
E Daily Stock Pick: Bristol-Myers Squibb
Article By: Fredrik Arnold Wednesday, July 3, 2019 5:31 AM EST
Bristol's price per share closed at $46.71 yesterday. A year ago its price was $55.65.
In this article: BMY
Read
Bulls & Bears Of The Week: AT&T, Carnival, McDonald's, Microsoft And More
Article By: Benzinga Saturday, June 29, 2019 7:49 PM EST
Benzinga continues to examine the prospects for many of the stocks most popular with investors. Here are just a few of this past week's most bullish and bearish posts that may be worth another look.
In this article: BMY, CCL, CRM, MCD, RTN, T, MSFT, ACB, UTX
Read
Shifting Options Strategy To More Defensive
Article By: Financial Velociraptor Saturday, June 8, 2019 1:28 AM EST
My options strategy continues to evolve into something that is better positioned to weather a bear market.
In this article: EL, BMY, CB, DIS, JPM, ZTS, INTC, ECL, AVGO, JNJ, UNH, NVO, BKNG
Read
1 to 16 of 192 Posts
1 2 3 ... 12